TVARDI THERAPEUTICS, INC. Investment Income, Interest
TVARDI THERAPEUTICS, INC. (TVRD) reported Investment Income, Interest of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-06-30 was $200.00K, a 100.00% increase year-over-year.
- TVARDI THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-12-31 was $100.00K, a 0.00% change year-over-year.
- TVARDI THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-09-30 was $300.00K, a 50.00% increase year-over-year.
- TVARDI THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-06-30 was $100.00K, a 50.00% decline year-over-year.
- TVARDI THERAPEUTICS, INC. investment income, interest for fiscal 2025 was $700.00K, a 0.00% change from fiscal 2024.
- TVARDI THERAPEUTICS, INC. investment income, interest for fiscal 2024 was $700.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-14 | $300.00K 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $400.00K derived: sum of 2 quarters · filed 2026-03-31 | $500.00K derived: sum of 3 quarters · filed 2026-08-14 | $700.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2026-08-14 | $600.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-14 | $300.00K 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $300.00K derived: sum of 2 quarters · filed 2026-03-31 | $500.00K derived: sum of 3 quarters · filed 2026-03-31 | $700.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2025-11-13 | $600.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-14 | $500.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |